Drug intelligence / Profile preview

immepip

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal, Intracerebroventricular (animal Research Only)
01

Overview

Immepip is a synthetic small molecule that acts as a potent and selective agonist at the histamine H3 receptor, equipotent to or more active than (R)-α-methylhistamine. It also acts as an agonist at the histamine H4 receptor, though with lower potency. Immepip is widely used in research to study the roles of H3 and H4 histamine receptors, including regulation of neurotransmitter release, sleep/wake cycle, and feeding behaviors. It displays little to no activity at histamine H1 or H2 receptors and is generally used as a pharmacological tool compound for in vitro and in vivo studies. Immepip is not approved for clinical use or marketed for therapeutic indications.

Other names
4-(1H-imidazol-4-ylmethyl)piperidinepiperidine 4-(1H-imidazol-4-ylmethyl)-immepip dihydrobromide
02

Targets

HRH4 (Histamine H4 receptor)HRH3 (Histamine Receptor H3)

Beyond the preview

Go deeper on immepip.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on immepip.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call